✨
AI Summary
- Dr. Ahmed Enayetallah on Parkinson's trial.
- BlueRock Therapeutics' use of iPSCs.
- Discusses bemdaneprocel and positive trial trends.
Guests on This Episode
AE
Ahmed Enayetallah
1 podcast appearance